Fundz

Enterome raises $19M in funding to advance its Phase 1/2 trial of EO2463 OncoMimics for treating indolent non-Hodgkin lymphoma.

PRIVATEJun 12, 2025

Amount Raised

$19 Million

Round Type

Funding Round

ParisBiotechnologyTherapeuticsPharmaceutical

Description

Enterome, a Paris-based clinical-stage company, raised $19M in funding. The company intends to use the funds to advance its Phase 1/2 trial of EO2463 OncoMimics. This treatment targets multiple forms of indolent non-Hodgkin lymphoma. Led by CEO Pierre Bélichard, Enterome focuses on innovative immunotherapies for cancer.

Quick answer

Enterome raised $19 Million in a Funding Round round, dated June 12, 2025. Enterome is based in Paris, Ile-de-France, France.

How much did Enterome raise?
Enterome raised $19 Million in a Funding Round round on June 12, 2025.
What does Enterome do?
Enterome is a clinical-stage biopharmaceutical company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.
Where is Enterome based and how big is it?
Enterome is based in Paris, Ile-de-France, France.
Who are the decision-makers at Enterome?
Fundz holds 1 contact at Enterome. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Pharmaceutical around the same time

Companies in the same sectors as Enterome that raised within 45 days of this round, from Fundz verified event records.

  • BioSapien raised $8M (Pre-Series A) on July 7, 2025.
  • Pelthos Therapeutics raised $50M on July 1, 2025.
  • Biofrontera raised $11M on June 27, 2025.
  • Os Therapies raised $4.2M on June 23, 2025.
  • Acurx Pharmaceuticals raised $4M (Seed) on June 17, 2025.
  • Ensho Therapeutics raised $23M on June 12, 2025.

Who to call at Enterome, and when

A new round usually means Enterome is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Enterome raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Enterome, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Enterome. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Enterome

Location

Paris, Ile-de-France, France

About

Enterome is a clinical-stage biopharmaceutical company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases. Enterome’s pioneering approach to drug discovery is based on its unique and powerful bacterial Mimicry drug discovery platform, which allows it to analyze and uncover new biological insights from the millions of gut bacterial proteins in constant cross-talk with the human body.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Enterome raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Enterome's next move

See what Strategic adds

Enterome raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.